Synonyms: CGX-635 | HHT | homoharringtonine | Myelostat® | Synribo®
omacetaxine mepesuccinate is an approved drug (FDA (2012))
Compound class:
Natural product
Comment: Omacetaxine mepesuccinate is a semi-synthetic derivative of the alkaloid cephalotaxine from Cephalotaxus harringtonia. Note that this compound is represented on Drugbank with slightly different stereochemistry by the entry DB04865.
|
|
References |
1. Cai Z, Lin M, Wuchter C, Ruppert V, Dörken B, Ludwig WD, Karawajew L. (2001)
Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation. Leukemia, 15 (4): 567-74. [PMID:11368358] |
2. Fresno M, Jiménez A, Vázquez D. (1977)
Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem, 72 (2): 323-30. [PMID:319998] |
3. Ianevski A, Yao R, Fenstad MH, Biza S, Zusinaite E, Reisberg T, Lysvand H, Løseth K, Landsem VM, Malmring JF et al.. (2020)
Potential Antiviral Options against SARS-CoV-2 Infection. Viruses, 12 (6). [PMID:32545799] |
4. Tscherne JS, Pestka S. (1975)
Inhibition of protein synthesis in intact HeLa cells. Antimicrob Agents Chemother, 8 (4): 479-87. [PMID:1190754] |
5. Zhou DC, Zittoun R, Marie JP. (1995)
Homoharringtonine: an effective new natural product in cancer chemotherapy. Bull Cancer, 82 (12): 987-95. [PMID:8745664] |